MICRONISED PROGESTERONE PHARMACEUTICAL COMPOSITION AND USES THEREOF

MICRONISED PROGESTERONE PHARMACEUTICAL COMPOSITION AND USES THEREOF

A pharmaceutical composition (C1) comprises micronized progesterone and safflower oil type II. An independent claim is included for a pharmaceutical product comprising a composition (C1) where the product is in the form of a dosage unit of 2-600 mg of micronized progesterone. ACTIVITY : Gynecologica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TERRACOL DIDIER, GICQUEL JENNIFER, SAMOYEAU ROLAND
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TERRACOL DIDIER
GICQUEL JENNIFER
SAMOYEAU ROLAND
description A pharmaceutical composition (C1) comprises micronized progesterone and safflower oil type II. An independent claim is included for a pharmaceutical product comprising a composition (C1) where the product is in the form of a dosage unit of 2-600 mg of micronized progesterone. ACTIVITY : Gynecological; Osteopathic; Cytostatic; Anticonvulsant. No biological data given. MECHANISM OF ACTION : None given.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201100605B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201100605B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201100605B3</originalsourceid><addsrcrecordid>eNrjZHD29XQO8vfzDHZ1UQgI8nd3DQ5xBfJdFQI8HIN8HZ1dQ0M8nR19FJz9fQP8gz1DPP39FBz9XBRCg12DFUI8XINc_d14GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8lKORgaGhgYGZgamTMTFqAGeuK98</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MICRONISED PROGESTERONE PHARMACEUTICAL COMPOSITION AND USES THEREOF</title><source>esp@cenet</source><creator>TERRACOL DIDIER ; GICQUEL JENNIFER ; SAMOYEAU ROLAND</creator><creatorcontrib>TERRACOL DIDIER ; GICQUEL JENNIFER ; SAMOYEAU ROLAND</creatorcontrib><description>A pharmaceutical composition (C1) comprises micronized progesterone and safflower oil type II. An independent claim is included for a pharmaceutical product comprising a composition (C1) where the product is in the form of a dosage unit of 2-600 mg of micronized progesterone. ACTIVITY : Gynecological; Osteopathic; Cytostatic; Anticonvulsant. No biological data given. MECHANISM OF ACTION : None given.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120425&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201100605B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120425&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201100605B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TERRACOL DIDIER</creatorcontrib><creatorcontrib>GICQUEL JENNIFER</creatorcontrib><creatorcontrib>SAMOYEAU ROLAND</creatorcontrib><title>MICRONISED PROGESTERONE PHARMACEUTICAL COMPOSITION AND USES THEREOF</title><description>A pharmaceutical composition (C1) comprises micronized progesterone and safflower oil type II. An independent claim is included for a pharmaceutical product comprising a composition (C1) where the product is in the form of a dosage unit of 2-600 mg of micronized progesterone. ACTIVITY : Gynecological; Osteopathic; Cytostatic; Anticonvulsant. No biological data given. MECHANISM OF ACTION : None given.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD29XQO8vfzDHZ1UQgI8nd3DQ5xBfJdFQI8HIN8HZ1dQ0M8nR19FJz9fQP8gz1DPP39FBz9XBRCg12DFUI8XINc_d14GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8lKORgaGhgYGZgamTMTFqAGeuK98</recordid><startdate>20120425</startdate><enddate>20120425</enddate><creator>TERRACOL DIDIER</creator><creator>GICQUEL JENNIFER</creator><creator>SAMOYEAU ROLAND</creator><scope>EVB</scope></search><sort><creationdate>20120425</creationdate><title>MICRONISED PROGESTERONE PHARMACEUTICAL COMPOSITION AND USES THEREOF</title><author>TERRACOL DIDIER ; GICQUEL JENNIFER ; SAMOYEAU ROLAND</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201100605B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>TERRACOL DIDIER</creatorcontrib><creatorcontrib>GICQUEL JENNIFER</creatorcontrib><creatorcontrib>SAMOYEAU ROLAND</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TERRACOL DIDIER</au><au>GICQUEL JENNIFER</au><au>SAMOYEAU ROLAND</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MICRONISED PROGESTERONE PHARMACEUTICAL COMPOSITION AND USES THEREOF</title><date>2012-04-25</date><risdate>2012</risdate><abstract>A pharmaceutical composition (C1) comprises micronized progesterone and safflower oil type II. An independent claim is included for a pharmaceutical product comprising a composition (C1) where the product is in the form of a dosage unit of 2-600 mg of micronized progesterone. ACTIVITY : Gynecological; Osteopathic; Cytostatic; Anticonvulsant. No biological data given. MECHANISM OF ACTION : None given.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA201100605B
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title MICRONISED PROGESTERONE PHARMACEUTICAL COMPOSITION AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A06%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TERRACOL%20DIDIER&rft.date=2012-04-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201100605B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true